Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared

Regeneron vs. Walgreens: A Decade of Revenue Growth

__timestampRegeneron Pharmaceuticals, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014281955700076392000000
Thursday, January 1, 20154103728000103444000000
Friday, January 1, 20164860427000117351000000
Sunday, January 1, 20175872227000118214000000
Monday, January 1, 20186710800000131537000000
Tuesday, January 1, 20197863400000120074000000
Wednesday, January 1, 20208497100000121982000000
Friday, January 1, 202116071700000132509000000
Saturday, January 1, 202212172900000132703000000
Sunday, January 1, 202313117200000139081000000
Monday, January 1, 202414202000000147658000000
Loading chart...

Unleashing the power of data

A Tale of Two Giants: Regeneron vs. Walgreens

In the ever-evolving landscape of the pharmaceutical and retail sectors, Regeneron Pharmaceuticals, Inc. and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, Regeneron showcased a remarkable revenue growth, surging from approximately $2.8 billion to $13.1 billion, marking an impressive 365% increase. In contrast, Walgreens, a retail behemoth, maintained a steady revenue stream, growing from $76.4 billion to $139.1 billion, a 82% rise over the same period.

Key Insights

  • Regeneron's Leap: The year 2021 was pivotal for Regeneron, with revenues peaking at $16.1 billion, a testament to its innovative prowess.
  • Walgreens' Consistency: Despite the challenges of the retail sector, Walgreens demonstrated resilience, with revenues consistently above $100 billion since 2015.

This comparison highlights the dynamic nature of these industries, where innovation and stability play crucial roles in shaping financial trajectories.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025